Hair Growth Treatment

Follica Publishes New Women’s Hair Growth Study

December 9, 2020 /

Follica announced today the completion of a female pilot study utilizing its proprietary microneedling device along with topical drug application. Female Hair Growth Study On December 8, 2020, a peer-reviewed study sponsored by Follica and titled “A Pilot Evaluation of Scalp Skin Wounding to Promote Hair Growth in Female Pattern Hair Loss” was published in…

CRISPR/Cas9 Therapy For Androgenic Alopecia: Moogene Medi

November 29, 2020 /

Moogene Medi of South Korea is the first company to formally introduce a CRISPR-based gene editing hair loss therapy to the world.  Description Of CRISPR Therapy For AGA Moogene has developed a microbubble-nanoliposomal delivery system to get gene editing particles directly into the dermal papilla cells of the hair follicle. First, a sequence of sgRNA…

SULT1A1 Minoxidil Response Booster Product: First Look

October 28, 2020 /

SULT1A1 + Minoxidil Human Study Published (Update 6/18/21) As foretold by Dr. Andy Goren below, Applied Biology has published a peer-reviewed study comparing the effect of the SULT1A1 booster in conjunction with minoxidil to minoxidil alone. The study titled “SULT1A1 (Minoxidil Sulfotransferase) Enzyme Booster Significantly Improves Response to Topical Minoxidil for Hair Regrowth” was published online…

Update On Dr. Tsuji’s Hair Multiplication Trial In 2020

August 8, 2020 /

Hair Growth Compounds In Development – Update (8/30/20) As mentioned in the original article, Dr. Tsuji also made an online presentation for the Adva Corporation on August 25, 2020. I attempted to attend the lecture but it seemed that residents outside of Japan were not permitted to join the Zoom conference. Luckily, our jovial Youtuber…

Koehler Lab Seeks Partners For Hair Cloning Technology

June 18, 2020 /

Koehler Lab Identifies Partner To Move Technology Forward: Update (7/7/21) About one year after this article was originally published, I have received a noteworthy update to share from Dr. Karl Koehler. Most importantly, as you read in the heading, an undisclosed company has stepped up to the plate to further Koehler’s research towards the clinic.…

Kintor Pharmaceuticals Furthers Baldness Treatment Drugs In US And China

May 26, 2020 /

US Male Phase 2 Pyrilutamide Trial Underway: Update (3/1/22) Consistent progress is the M.O. of Kintor Pharma. On March 1, 2022 it was announced that the first patients in a US phase 2 trial for males have received dosing. The four cohorts in the trial will receive topical dosing of either 2.5 mg pyrilutamide twice…

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.